miR-125a-5p expression is associated with the age of breast cancer patients

Genetics and Molecular Research

Volumn 14, Issue 4, 2015, Pages 17927-17933

  He, H ^a   Xu, F ^b   Huang, W ^a   Luo, S Y ^a   Lin, Y T ^a   Zhang, G H ^a   Du, Q ^a   Duan, R H ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Breast cancer; Clinicopathology; MicroRNA 125

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; MICRORNA; MICRORNA 125A 3P; MICRORNA 125A 5P; UNCLASSIFIED DRUG; ERBB2 PROTEIN, HUMAN; MIRN125 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BREAST CANCER; CANCER GRADING; CANCER GROWTH; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR VOLUME; AGE; BIOSYNTHESIS; BREAST TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGE FACTORS; AGED; BIOMARKERS, TUMOR; BREAST NEOPLASMS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHATIC METASTASIS; MICRORNAS; MIDDLE AGED; PROGNOSIS; RECEPTOR, ERBB-2;

EID: 84951855470     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: 10.4238/2015.December.22.17     Document Type: Article

References (21)

1. Alvarez-Garcia I and Miska EA (2005). MicroRNA functions in animal development and human disease. Development 132: 4653-4662.
2. Anders CK, Acharya CR, Hsu DS, Broadwater G, et al. (2008). Age-specific differences in oncogenic pathway deregulation seen in human breast tumors. PLoS One 3: e1373.
3. Bi Q, Tang S, Xia L, Du R, et al. (2012). Ectopic expression of MiR-125a inhibits the proliferation and metastasis of hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One 7: e40169.
4. Colak D, Nofal A, Albakheet A, Nirmal M, et al. (2013). Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One 8: e63204.
5. Gabriel CA and Domchek SM (2010). Breast cancer in young women. Breast Cancer Res. 12: 212.
6. Garzon R, Fabbri M, Cimmino A, Calin GA, et al. (2006). MicroRNA expression and function in cancer. Trends Mol. Med. 12: 580-587.
7. Guo X, Wu Y and Hartley RS (2009). MicroRNA-125a represses cell growth by targeting HuR in breast cancer. RNA Biol. 6: 575-583.
8. Kataoka A, Tokunaga E, Masuda N, Shien T, et al. (2014). Clinicopathological features of young patients (<35 years of age) with breast cancer in a Japanese Breast Cancer Society supported study. Breast Cancer 21: 643-650.
9. Narod SA (2012). Breast cancer in young women. Nat. Rev. Clin. Oncol. 9: 460-470.
10. Nishida N, Yokobori T, Mimori K, Sudo T, et al. (2011). MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int. J. Oncol. 38: 1437-1443.
11. Peña-Chilet M, Martínez MT, Pérez-Fidalgo JA, Peiró-Chova L, et al. (2014). MicroRNA profile in very young women with breast cancer. BMC Cancer 14: 529.
12. Pirone JR, D'Arcy M, Stewart DA, Hines WC, et al. (2012). Age-associated gene expression in normal breast tissue mirrors qualitative age-at-incidence patterns for breast cancer. Cancer Epidemiol. Biomarkers Prev. 21: 1735-1744.
13. Saetrom P, Biesinger J, Li SM, Smith D, et al. (2009). A risk variant in an miR-125b binding site in BMPR1B is associated with breast cancer pathogenesis. Cancer Res. 69: 7459-7465.
14. Scott GK, Goga A, Bhaumik D, Berger CE, et al. (2007). Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J. Biol. Chem. 282: 1479-1486.
15. Shaham L, Binder V, Gefen N, Borkhardt A, et al. (2012). MiR-125 in normal and malignant hematopoiesis. Leukemia. 26: 2011-2018.
16. Sun YM, Lin KY and Chen YQ (2013). Diverse functions of miR-125 family in different cell contexts. J. Hematol. Oncol. 6: 6.
17. Tang F, Zhang R, He Y, Zou M, et al. (2012). MicroRNA-125b induces metastasis by targeting STARD13 in MCF-7 and MDA-MB-231 breast cancer cells. PLoS One 7: e35435.
18. Turkoz FP, Solak M, Petekkaya I, Keskin O, et al. (2013). Association between common risk factors and molecular subtypes in breast cancer patients. Breast 22: 344-350.
19. Vriens MR, Weng J, Suh I, Huynh N, et al. (2012). MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118: 3426-3432.
20. Wang H, Tan G, Dong L, Cheng L, et al. (2012). Circulating MiR-125b as a marker predicting chemoresistance in breast cancer. PLoS One 7: e34210.
21. Wang S, Li H and Wang D (2013).Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn. Pathol. 21: 172.